Novanta Overview

  • Year Founded
  • 1968

Year Founded

  • Status
  • Public

  • Employees
  • 3,000

Employees

  • Stock Symbol
  • NOVT

Stock Symbol

  • Investments
  • 30

  • Share Price
  • $118.86
  • (As of Friday Closing)

Novanta General Information

Description

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Contact Information

Website
www.novanta.com
Formerly Known As
Gsi Lumonics, GSI Group, General Scanning, Lumonics
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 125 Middlesex Turnpike
  • Bedford, MA 01730
  • United States
+1 (781)
Primary Industry
Other Devices and Supplies
Other Industries
Electrical Equipment
Stock Exchange
NAS
Corporate Office
  • 125 Middlesex Turnpike
  • Bedford, MA 01730
  • United States
+1 (781)

Novanta Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novanta Stock Performance

As of 13-Nov-2026, Novanta’s stock price is $118.86. Its current market cap is $4.5B with 37.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$118.86 $117.42 $98.27 - $176.38 $4.5B 37.8M 426K $1.32

Novanta Financials Summary

As of 30-Sep-2026, Novanta has a trailing 12-month revenue of $1.09B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,943,380 4,672,141 5,909,300 6,358,952
Revenue 1,086,871 980,600 949,245 881,662
EBITDA 158,841 153,046 166,118 156,178
Net Income 53,128 53,829 64,087 72,878
Total Assets 3,173,046 1,807,106 1,388,511 1,226,056
Total Debt 893,246 301,907 470,242 404,558
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novanta Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novanta‘s full profile, request access.

Request a free trial

Novanta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging propri
Other Devices and Supplies
Bedford, MA
3,000 As of 2025

Oberkochen, Germany
 

Murphy, NC
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novanta Competitors (9)

One of Novanta’s 9 competitors is ZEISS (Germany), a Formerly PE-Backed company based in Oberkochen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ZEISS (Germany) Formerly PE-Backed Oberkochen, Germany
Moog Animatics Corporate Backed or Acquired Murphy, NC
Toptica Accelerator/Incubator Backed Munich, Germany
MKS (Electronic Equipment and Instruments) Corporation Andover, MA
Edmund Optics Corporation Barrington, NJ
You’re viewing 5 of 9 competitors. Get the full list »

Novanta Patents

Novanta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260309548-A1 Method and apparatus for segmented spectral measurement using od filters for nvis radiance calculation Pending 07-Apr-2025
US-20260298672-A1 Filtering photodetector for use in optical encoders Pending 27-Mar-2025
WO-2026207499-A1 Filtering photodetector for use in optical encoders Pending 27-Mar-2025
GB-202504405-D0 Gas bearing spindles and gas bearing assemblies for gas bearing spindles Pending 26-Mar-2025
GB-2705810-A Gas bearing spindles and gas bearing assemblies for gas bearing spindles Pending 26-Mar-2025 B26D7/00
To view Novanta’s complete patent history, request access »

Novanta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novanta Investments & Acquisitions (30)

Novanta’s most recent deal was a Merger/Acquisition with Riverpoint Medical for . The deal was made on 23-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Riverpoint Medical 23-Jul-2026 Merger/Acquisition Surgical Devices
Runway Buyer 23-Jul-2026 Merger/Acquisition Surgical Devices
Keonn 08-Apr-2025 Merger/Acquisition Other Hardware
Motion Solutions 02-Jan-2024 Merger/Acquisition Electronic Equipment and Instruments
Novanta Medical 11-Aug-2022 Merger/Acquisition Medical Supplies
You’re viewing 5 of 30 investments and acquisitions. Get the full list »

Novanta ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

9.13 | Negl Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Technology Hardware

Industry

of 556

Rank

Percentile

Electronics Equipment

Subindustry

of 106

Rank

Percentile

To view Novanta’s complete esg history, request access »

Novanta Exits (1)

Novanta’s most recent exit was on 21-Sep-2000 from General Optics (Fiberoptic Equipment). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
General Optics (Fiberoptic Equipment) 21-Sep-2000 Completed
To view Novanta’s complete exits history, request access »

Novanta Affiliates

Subsidiaries (6)

Name Industry Location Year Founded
Riverpoint Medical Portland, OR 2008
Keonn Barcelona, Spain 2008
Jadak Technologies Syracuse, NY 2000
Reach Technology Lake Oswego, OR 1988
Novanta IMS Marlborough, CT 1986
You’re viewing 5 of 6 affiliates. Get the full list.  »

Novanta FAQs

  • When was Novanta founded?

    Novanta was founded in 1968.

  • Where is Novanta headquartered?

    Novanta is headquartered in Bedford, MA.

  • What is the size of Novanta?

    Novanta has 3,000 total employees.

  • What industry is Novanta in?

    Novanta’s primary industry is Other Devices and Supplies.

  • Is Novanta a private or public company?

    Novanta is a Public company.

  • What is Novanta’s stock symbol?

    The ticker symbol for Novanta is NOVT.

  • What is the current stock price of Novanta?

    As of 13-Nov-2026 the stock price of Novanta is $118.86.

  • What is the current market cap of Novanta?

    The current market capitalization of Novanta is $4.5B.

  • What is Novanta’s current revenue?

    The trailing twelve month revenue for Novanta is $1.09B.

  • Who are Novanta’s competitors?

    ZEISS (Germany), Moog Animatics, Toptica, MKS (Electronic Equipment and Instruments), and Edmund Optics are some of the 9 competitors of Novanta.

  • What is Novanta’s annual earnings per share (EPS)?

    Novanta’s EPS for 12 months was $1.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process